|
1
|
Dall TM, Yang W, Halder P, Pang B,
Massoudi M, Wintfeld N, Semilla AP, Franz J and Hogan PF: The
economic burden of elevated blood glucose levels in 2012: Diagnosed
and undiagnosed diabetes, gestational diabetes mellitus, and
prediabetes. Diabetes Care. 37:3172–3179. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Patterson CC, Karuranga S, Salpea P,
Saeedi P, Dahlquist G, Soltesz G and Ogle GD: Worldwide estimates
of incidence, prevalence and mortality of type 1 diabetes in
children and adolescents: Results from the International diabetes
federation diabetes atlas, 9th edition. Diabetes Res Clin Pract.
157(107842)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yau JW, Rogers SL, Kawasaki R, Lamoureux
EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund
J, et al: Global prevalence and major risk factors of diabetic
retinopathy. Diabetes Care. 35:556–564. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Savage SR, McCollum GW, Yang R and Penn
JS: RNA-seq identifies a role for the PPARβ/δ inverse agonist
GSK0660 in the regulation of TNFα-induced cytokine signaling in
retinal endothelial cells. Mol Vis. 21:568–576. 2015.PubMed/NCBI
|
|
5
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pan C, Wang X, Shi K, Zheng Y, Li J, Chen
Y, Jin L and Pan Z: MiR-122 reverses the doxorubicin-resistance in
hepatocellular carcinoma cells through regulating the tumor
metabolism. PLoS One. 11(e0152090)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Reichholf B, Herzog VA, Fasching N,
Manzenreither RA, Sowemimo I and Ameres SL: Time-resolved small RNA
sequencing unravels the molecular principles of microRNA
homeostasis. Mol Cell. 75:756–768.e7. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ruiz MA, Feng B and Chakrabarti S:
Polycomb repressive complex 2 regulates MiR-200b in retinal
endothelial cells: Potential relevance in diabetic retinopathy.
PLoS One. 10(e0123987)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ding L, Ni J, Yang F, Huang L, Deng H, Wu
Y, Ding X and Tang J: Promising therapeutic role of miR-27b in
tumor. Tumour Biol. 39(1010428317691657)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li T, Wu Q, Liu D and Wang X: MiR-27b
Suppresses tongue squamous cell carcinoma epithelial-mesenchymal
transition by targeting ITGA5. Onco Targets Ther. 13:11855–11867.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liu CH, Jing XN, Liu XL, Qin SY, Liu MW
and Hou CH: Tumor-suppressor miRNA-27b-5p regulates the growth and
metastatic behaviors of ovarian carcinoma cells by targeting CXCL1.
J Ovarian Res. 13(92)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Murai N, Saiki R, Hashizume M, Kigawa Y,
Koizumi G, Tadokoro R, Endo K, Iizaka T, Otsuka F, Izumizaki M and
Nagasaka S: Alcohol flushing is independently associated with
lesser degree of carotid atherosclerosis in Japanese type 2
diabetic patients. Diabetol Int. 9:68–74. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chong PL, Pisharam J, Abdullah A and Chong
VH: Gestational diabetes insipidus. QJM. 112:123–124.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wong TY and Sabanayagam C: The war on
diabetic retinopathy: Where are we now? Asia Pac J Ophthalmol
(Phila). 8:448–456. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wilson M, Chen HS and Wood M: Impact of
nurse champion on quality of care and outcomes in type 2 diabetes
patients. Int J Evid Based Healthc. 17:3–13. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Allen D: The nurse's role in childhood
diabetes. Nurs Child Young People. 28(11)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mohammad HMF, Sami MM, Makary S, Toraih
EA, Mohamed AO and El-Ghaiesh SH: Neuroprotective effect of
levetiracetam in mouse diabetic retinopathy: Effect on glucose
transporter-1 and GAP43 expression. Life Sci.
232(116588)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Clore JN and Thurby-Hay L:
Glucocorticoid-induced hyperglycemia. Endocr Pract. 15:469–474.
2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xie LB, Chen B, Liao X, Chen YF, Yang R,
He SR, Pei LJ and Jiang R: LINC00963 targeting miR-128-3p promotes
acute kidney injury process by activating JAK2/STAT1 pathway. J
Cell Mol Med. 24:5555–5564. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang L, Han S, Jin G, Zhou X, Li M, Ying
X, Wang L, Wu H and Zhu Q: Linc00963: A novel, long non-coding RNA
involved in the transition of prostate cancer from
androgen-dependence to androgen-independence. Int J Oncol.
44:2041–2049. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang N, Zeng X, Sun C, Guo H, Wang T, Wei
L, Zhang Y, Zhao J and Ma X: LncRNA LINC00963 promotes
tumorigenesis and radioresistance in breast cancer by sponging
miR-324-3p and inducing ACK1 expression. Mol Ther Nucleic Acids.
18:871–881. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wu JH, Tian XY, An QM, Guan XY and Hao CY:
LINC00963 promotes hepatocellular carcinoma progression by
activating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci.
22:1645–1652. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jiao H, Jiang S, Wang H, Li Y and Zhang W:
Upregulation of LINC00963 facilitates melanoma progression through
miR-608/NACC1 pathway and predicts poor prognosis. Biochem Biophys
Res Commun. 504:34–39. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhou N, Zhu X and Man L: LINC00963
functions as an oncogene in bladder cancer by regulating the
miR-766-3p/MTA1 axis. Cancer Manag Res. 12:3353–3361.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chatzileontiadou DSM, Samiotaki M,
Alexopoulou AN, Cotsiki M, Panayotou G, Stamatiadi M, Balatsos NAA,
Leonidas DD and Kontou M: Proteomic analysis of human angiogenin
interactions reveals cytoplasmic PCNA as a putative binding
partner. J Proteome Res. 16:3606–3622. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang X, Wang D, Yuan N, Liu F, Wang F,
Wang B and Zhou D: The prognostic value of PCNA expression in
patients with osteosarcoma: A meta-analysis of 16 studies. Medicine
(Baltimore). 96(e8254)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Rahmanzadeh R, Huttmann G, Gerdes J and
Scholzen T: Chromophore-assisted light inactivation of pKi-67 leads
to inhibition of ribosomal RNA synthesis. Cell Prolif. 40:422–430.
2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Scholzen T and Gerdes J: The Ki-67
protein: From the known and the unknown. J Cell Physiol.
182:311–322. 2000.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Feng Q, Wu X, Li F, Ning B, Lu X, Zhang Y,
Pan Y and Guan W: MiR-27b inhibits gastric cancer metastasis by
targeting NR2F2. Protein Cell. 8:114–122. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Urbich C, Kaluza D, Fromel T, Knau A,
Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN,
Hergenreider E, et al: MicroRNA-27a/b controls endothelial cell
repulsion and angiogenesis by targeting semaphorin 6A. Blood.
119:1607–1616. 2012.PubMed/NCBI View Article : Google Scholar
|
